01 33BDSI
02 16INDIVIOR
03 52OREXO US INC
04 1REACX PHARMS
01 17736665
02 108147866
03 68470361
04 48475832
05 48603514
06 68658198
07 38703177
08 68940330
09 69259421
10 69439900
11 39522188
12 109655843
13 49687454
14 79901539
15 110874661
16 610946010
17 411020387
18 611020388
19 411135216
20 511433066
01 102Blank
01 89Y
02 13Blank
01 42024-04-03
02 12024-04-25
03 202027-07-23
04 62027-12-03
05 82029-08-07
06 42030-03-26
07 62030-05-22
08 32032-08-20
09 402032-09-18
10 72032-12-21
11 32035-04-24
Patent Expiration Date : 2032-12-21
US Patent Number : 9901539
Drug Substance Claim :
Drug Product Claim :
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2032-12-21
Patent Expiration Date : 2032-12-21
US Patent Number : 9901539
Drug Substance Claim :
Drug Product Claim :
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2032-12-21
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-1521
Delist Requested :
Patent Use Description : MAINTENANCE TREATMENT ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1769
Delist Requested :
Patent Use Description : TREATEMENT OF PAIN BY ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1769
Delist Requested :
Patent Use Description : TREATEMENT OF PAIN BY ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1556
Delist Requested :
Patent Use Description : MANAGEMENT OF PAIN SEV...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207932
Patent Use Code : U-1769
Delist Requested :
Patent Use Description : TREATEMENT OF PAIN BY ...
Patent Expiration Date : 2027-07-23
LOOKING FOR A SUPPLIER?
